
Adjuvant Pembrolizumab (NSCLC), Elacestrant, & Pirtobrutinib
OncoPharm
00:00
Intro
John Bizarro introduces OncoPharm, the episode date, and teases recent FDA updates and approvals.
Play episode from 00:00
Transcript

John Bizarro introduces OncoPharm, the episode date, and teases recent FDA updates and approvals.